Trademarkia Logo

Canada

C$
Trademark Search in Canada
VYVANSE

View On IC.GC.CA

VYVANSE
REGISTERED

on 17 Sept 2009

Last Applicant/ Owned by

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall StreetCambridge, MA 02142

US

Serial Number

1329188 filed on 21st Dec 2006

Registration Number

TMA747942 registered on 17th Sept 2009

Registration expiry Date

17th Sept 2034

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

VYVANSE

Trademark usage description

pharmaceutical preparations for the treatment of disorders of the central nervous system, namely for the treatment of attention deficit disorder and h Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely for the treatment of attention deficit disorder and hyperactivity.

Classification kind code

12

Mark Details

Serial Number

1329188

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 5th Mar 2009		Approved
Submitted for opposition 27
on 15th Jan 2009		Approval Notice Sent
Submitted for opposition 12
on 21st Jul 2008		Extension of Time
Submitted for opposition 15
on 28th Nov 2007		Correspondence Created
Submitted for opposition 15
on 12th Sept 2007		Correspondence Created
Submitted for opposition 22
on 14th May 2007		Search Recorded
Submitted for opposition 20
on 14th May 2007		Examiner's First Report
Submitted for opposition 31
on 22nd Dec 2006		Formalized
Submitted for opposition 30
on 21st Dec 2006		Filed
Submitted for opposition 1
on 21st Dec 2006		Created